Clinical Trials Browser

Phase 3 × Unknown × Mercaptopurine × Clear all

Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT00003437 2013-12-04

Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia

Phase 3 Unknown

1,800 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002701 2013-09-20

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

Phase 3 Unknown

750 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00047268 2013-09-17

Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome

Phase 3 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00764907 2009-07-08

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

Phase 3 Unknown

4,000 enrolled

Other hematologic neoplasm

Leukemia

NCT00131027 2008-11-14

High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)

Phase 3 Unknown

240 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)